Central DuPage Hospital - About CDH - Newsroom - Press Releases - 2010 - CDH Participates in National Blood Clot Treatment Study
Central DuPage Hospital Logo

Ortho Award

Text Size Default Text Size button Medium Text Size button Large Text Size button
Share | Facebook Twitter YouTube
2010: CDH Participates in National Blood Clot Treatment Study
<< Back to 2010

CDH Participates in National Blood Clot Treatment Study

WINFIELD, Ill., March 10, 2010 - Central DuPage Hospital (CDH) is one of just 47 hospitals and medical institutions in the U.S. taking part in an important National Institutes of Health (NIH) funded research study to evaluate the efficacy of a new approach to treating deep vein thrombosis (DVT).
 
“This NIH sponsored study puts CDH in the company of facilities like Cleveland Clinic, Georgetown University Hospital and Stanford University Medical Center,” said CDH Research Director Julie Jones, MBA, CHRC. “Many people don’t realize that non-academic hospitals can qualify for research like this because very few community hospitals have the capability to do so. CDH has 32 trials open right now and working with the National Institutes of Health is quite an accomplishment.”

In late 2008, the Surgeon General issued a National Call to Action to warn Americans about the dangers of blood clots. This call to action specifically noted the importance of studying clot-busting treatments such as the procedure being researched at CDH as part of the ATTRACT (Acute Venous Thrombosis: Thrombus Removal with Adjunctive Cather-Directed Thrombolysis) Study. The ATTRACT Study will help determine if DVT can be treated safely and effectively by injecting the clot-busting drug tPA directly into the clot through a catheter. Researchers hope that this treatment may relieve DVT symptoms faster than other treatments and also prevent the vein damage that leads to post-thrombotic syndrome (PTS), a painful and chronic condition.

“CDH is very pleased to be working with the National Institutes of Health,” said Joseph Schneider, MD, PhD., FACS, principal investigator and one of the three physicians on the medical staff at CDH leading the ATTRACT Study. “Research is one way we can participate in improving care. We’re excited to be a part of making our future generations healthier.”

The ATTRACT Study research conducted at CDH is sponsored by the NIH via the National Heart, Lung and Blood Institute, and it will be led by Schneider, Nilesh Patel, MD, and Stanley Kim, MD, all partners in the Central DuPage Physician Group’s Vascular and Interventional Program. This team of physicians from the CDH medical staff is working to determine if a new, catheter-based treatment procedure is an effective and safe way to remove a blood clot.

About Central DuPage Hospital
Central DuPage Hospital (CDH) is a nationally recognized 313-bed facility located in Winfield, Ill., a suburb west of Chicago. CDH is a leading center for medical technology and one of the busiest surgical centers in Illinois.

For the last three consecutive years, Thomson Reuter’s has listed CDH as a 100 Top Hospital in the U.S. Similarly, U.S. News & World Report has included CDH on their list of Best Hospitals in the orthopaedics category each year since 2007.

The hospital is part of an interdependent network of health-care organizations and services, including convenient care centers, occupational health services, home health and hospice care. For more information or to find a doctor on the medical staff of CDH, visit www.cdh.org or call 630-933-4CDH (4234)/ TTY 630-933-4833 for the hearing impaired.

Contact
Christopher King
630-933-5117
630-776-5373 (cell)